Inhibition by uridine but not thymidine of p53-dependent intestinal apoptosis initiated by 5-fluorouracil: evidence for the involvement of RNA perturbation.
Affiliation
Department of Epithelial Cell Biology, The Paterson Institute for Cancer Research, Christie Hospital Trust, Manchester, United Kingdom.Issue Date
1997-03-04
Metadata
Show full item recordAbstract
The epithelia from the crypts of the intestine are exquisitely sensitive to metabolic perturbation and undergo cell death with the classical morphology of apoptosis. Administration of 40 mg/kg 5-fluorouracil (5-FU) to BDF-1 p53+/+ mice resulted in an increase in p53 protein at cell positions in the crypts that were also those subjected to an apoptotic cell death. In p53-/- mice apoptosis was almost completely absent, even after 24 hr. 5-FU is a pyrimidine antimetabolite cytotoxin with multiple mechanisms of action, including inhibition of thymidylate synthase (TS), which gives rise to DNA damage, and incorporation into RNA. The inhibition of TS can be increased by coadministration of folinic acid and can be abrogated by administration of thymidine. The incorporation of 5-FU into RNA is inhibited by administration of uridine. p53-Dependent cell death induced by 5-FU was only inhibited by administration of uridine. Uridine had no effect on the apoptosis initiated by 1 Gy of gamma-radiation. Although thymidine abrogated apoptosis induced by the pure TS inhibitor Tomudex, it had no effect on 5-FU-induced apoptosis, and coadministration of folinic acid did not increase apoptosis. The data show that 5-FU-induced cell death of intestinal epithelial cells is p53-dependent and suggests that changes in RNA metabolism initiate events culminating in the expression of p53.Citation
Inhibition by uridine but not thymidine of p53-dependent intestinal apoptosis initiated by 5-fluorouracil: evidence for the involvement of RNA perturbation. 1997, 94 (5):1795-9 Proc. Natl. Acad. Sci. USAJournal
Proceedings of the National Academy of Sciences of the United States of AmericaPubMed ID
9050858Type
ArticleLanguage
enISSN
0027-8424Collections
Related articles
- Mechanisms of acquired chemoresistance to 5-fluorouracil and tomudex: thymidylate synthase dependent and independent networks.
- Authors: Wang W, McLeod HL, Cassidy J, Collie-Duguid ES
- Issue date: 2007 May
- The role of thymidylate synthase induction in modulating p53-regulated gene expression in response to 5-fluorouracil and antifolates.
- Authors: Longley DB, Boyer J, Allen WL, Latif T, Ferguson PR, Maxwell PJ, McDermott U, Lynch M, Harkin DP, Johnston PG
- Issue date: 2002 May 1
- Synergistic efficacy of 3n-butyrate and 5-fluorouracil in human colorectal cancer xenografts via modulation of DNA synthesis.
- Authors: Bras-Gonçalves RA, Pocard M, Formento JL, Poirson-Bichat F, De Pinieux G, Pandrea I, Arvelo F, Ronco G, Villa P, Coquelle A, Milano G, Lesuffleur T, Dutrillaux B, Poupon MF
- Issue date: 2001 Mar
- Effect of folinic acid on fluorouracil activity and expression of thymidylate synthase.
- Authors: van der Wilt CL, Pinedo HM, Smid K, Cloos J, Noordhuis P, Peters GJ
- Issue date: 1992 Apr
- Differences in the induction of DNA damage, cell cycle arrest, and cell death by 5-fluorouracil and antifolates.
- Authors: Backus HH, Pinedo HM, Wouters D, Kuiper CM, Jansen G, van Groeningen CJ, Peters GJ
- Issue date: 2000